These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31690955)

  • 1. Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope.
    Martinenaite E; Ahmad SM; Bendtsen SK; Jørgensen MA; Weis-Banke SE; Svane IM; Andersen MH
    Cancer Immunol Immunother; 2019 Nov; 68(11):1901-1907. PubMed ID: 31690955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1-specific T cells.
    Ahmad SM; Borch TH; Hansen M; Andersen MH
    Cancer Immunol Immunother; 2016 Jul; 65(7):797-804. PubMed ID: 26724936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
    Weis-Banke SE; Lisle TL; Perez-Penco M; Schina A; Hübbe ML; Siersbæk M; Holmström MO; Jørgensen MA; Marie Svane I; Met Ö; Ødum N; Madsen DH; Donia M; Grøntved L; Andersen MH
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36316062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T-win® technology: immune-modulating vaccines.
    Andersen MH
    Semin Immunopathol; 2019 Jan; 41(1):87-95. PubMed ID: 29968045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Balance Players of the Adaptive Immune System.
    Andersen MH
    Cancer Res; 2018 Mar; 78(6):1379-1382. PubMed ID: 29440147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.
    Rodriguez PC; Quiceno DG; Zabaleta J; Ortiz B; Zea AH; Piazuelo MB; Delgado A; Correa P; Brayer J; Sotomayor EM; Antonia S; Ochoa JB; Ochoa AC
    Cancer Res; 2004 Aug; 64(16):5839-49. PubMed ID: 15313928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
    Weis-Banke SE; Hübbe ML; Holmström MO; Jørgensen MA; Bendtsen SK; Martinenaite E; Carretta M; Svane IM; Ødum N; Pedersen AW; Met Ö; Madsen DH; Andersen MH
    Oncoimmunology; 2020 Jun; 9(1):1771142. PubMed ID: 32923127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination.
    Pol JG; Bridle BW; Lichty BD
    Methods Mol Biol; 2020; 2058():191-211. PubMed ID: 31486039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors - A phase I trial.
    Lorentzen CL; Martinenaite E; Kjeldsen JW; Holmstroem RB; Mørk SK; Pedersen AW; Ehrnrooth E; Andersen MH; Svane IM
    Front Immunol; 2022; 13():1023023. PubMed ID: 36330525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors.
    Lennerz V; Gross S; Gallerani E; Sessa C; Mach N; Boehm S; Hess D; von Boehmer L; Knuth A; Ochsenbein AF; Gnad-Vogt U; Zieschang J; Forssmann U; Woelfel T; Kaempgen E
    Cancer Immunol Immunother; 2014 Apr; 63(4):381-94. PubMed ID: 24487961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic DNA vaccine targeting Foxp3
    Namdar A; Mirzaei R; Memarnejadian A; Boghosian R; Samadi M; Mirzaei HR; Farajifard H; Zavar M; Azadmanesh K; Elahi S; Noorbakhsh F; Rezaei A; Hadjati J
    Cancer Immunol Immunother; 2018 Mar; 67(3):367-379. PubMed ID: 29124314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO.
    Mondanelli G; Ugel S; Grohmann U; Bronte V
    Curr Opin Pharmacol; 2017 Aug; 35():30-39. PubMed ID: 28554057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
    de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
    Front Immunol; 2021; 12():592031. PubMed ID: 34335558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment.
    Pollack KE; Meneveau MO; Melssen MM; Lynch KT; Koeppel AF; Young SJ; Turner S; Kumar P; Sol-Church K; Mauldin IS; Slingluff CL
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32350119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
    Glöckner HJ; Martinenaite E; Landkildehus Lisle T; Grauslund J; Ahmad S; Met Ö; Thor Straten P; Hald Andersen M
    Oncoimmunology; 2024; 13(1):2318053. PubMed ID: 38404966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimotope vaccines for cancer immunotherapy.
    Sharav T; Wiesmüller KH; Walden P
    Vaccine; 2007 Apr; 25(16):3032-7. PubMed ID: 17276556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.
    Rodríguez PC; Ochoa AC
    Immunol Rev; 2008 Apr; 222():180-91. PubMed ID: 18364002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.
    Kyte JA; Trachsel S; Risberg B; thor Straten P; Lislerud K; Gaudernack G
    Cancer Immunol Immunother; 2009 Oct; 58(10):1609-26. PubMed ID: 19221745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.